Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €111.13 EUR
Change Today 0.00 / 0.00%
Volume 0.0
TBH On Other Exchanges
Symbol
Exchange
New York
As of 3:00 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TBH) Snapshot

Open
€111.13
Previous Close
€111.13
Day High
€111.13
Day Low
€111.13
52 Week High
07/7/15 - €126.58
52 Week Low
10/17/14 - €80.52
Market Cap
4.6B
Average Volume 10 Days
1.9
EPS TTM
--
Shares Outstanding
41.6M
EX-Date
08/12/15
P/E TM
--
Dividend
€1.37
Dividend Yield
1.05%
Current Stock Chart for TELEFLEX INC (TBH)

Related News

No related news articles were found.

teleflex inc (TBH) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TBH) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand. In addition, it offers surgical products, such as ligation clips and closure products; appliers and sutures used in surgical procedures; access ports for use in minimally invasive laparoscopic surgical procedures; robotic surgery and fluid management products for use in chest drainage; and reusable hand-held instruments for surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. Further, the company offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; specialized catheters; therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Additionally, it provides catheters, urine collectors, catheterization accessories, and products for operative endourology under the Rusch brand name; micro-laparoscopic instrumentation products; and original equipment manufacturing services. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,700 Employees
Last Reported Date: 02/20/15
Founded in 1943

teleflex inc (TBH) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $866.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $468.6K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $431.5K
Senior Vice President of Global Operations
Total Annual Compensation: $312.2K
Vice President of Global Human Resources
Total Annual Compensation: $281.8K
Compensation as of Fiscal Year 2014.

teleflex inc (TBH) Key Developments

Teleflex Signs New Agreement with Amerinet for Surgical Instruments

Teleflex Incorporated has been awarded a new Amerinet Choice® agreement with Amerinet. The agreement is effective August 1, 2015 through March 31, 2017. Through this new single source Choice agreement, Amerinet members will have access to an extensive line of handheld and laparoscopic surgical instruments, including well-established Pilling® and KMedic® products, at exclusive member rates.

Teleflex Incorporated Declares A Quarterly Cash Dividend, Payable on September 14, 2015

Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of 34 cents ($0.34) per share of common stock. The dividend is payable September 14, 2015 to shareholders of record at the close of business on August 14, 2015.

Teleflex Incorporated Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 28, 2015; Provides Earnings Guidance for the Year 2015

Teleflex Incorporated reported unaudited consolidated earnings results for the second quarter and six months ended June 28, 2015. For the quarter, the company reported net revenues of $452.045 million compared to $468.105 million a year ago. Income from continuing operations before interest and taxes was $76.986 million compared to $74.752 million a year ago. Income from continuing operations before taxes was $50.479 million compared to $58.836 million a year ago. Income from continuing operations was $45.199 million or $0.93 per diluted share compared to $48.830 million or $1.04 per diluted share a year ago. Net income attributable to common shareholders was $44.563 million or $0.93 per diluted share compared to $47.252 million or $1.02 per diluted share a year ago. Adjusted net income was $63.5 million or $1.42 per diluted share compared to $65.9 million or $1.51 per diluted share a year ago. For the six months, the company reported net revenues of $881.475 million compared to $906.651 million a year ago. Income from continuing operations before interest and taxes was $142.594 million compared to $133.772 million a year ago. Income from continuing operations before taxes was $99,084 million compared to $102.639 million a year ago. Income from continuing operations was $84.472 million or $1.76 per diluted share compared to $84.099 million or $1.81 per diluted share a year ago. Net income attributable to common shareholders was $82.915 million or $1.74 per diluted share compared to $82.210 million or $1.78 per diluted share a year ago. Net cash provided by operating activities from continuing operations was $109.588 million compared to $120.161 million a year ago. Expenditures for property, plant and equipment were $31.321 million compared to $30.850 million a year ago. Adjusted net income was $120.8 million or $2.72 per diluted share compared to $118.9 million or $2.73 per diluted share a year ago. Net debt obligations at June 28, 2015 were $816.7 million. The company continues to estimate that constant currency revenue growth will be between 4% and 6%. On a GAAP basis, revenues are expected to be flat to down 2% versus the prior year due to the unfavorable impact of foreign currency fluctuations. The company also continues to estimate that adjusted diluted earnings per share from continuing operations will be between $6.10 and $6.35, representing an increase of 6.3% to 10.6% over the prior year. Consistent with the previous expectations, the company anticipated that foreign currency fluctuations will negatively impact adjusted earnings per share in 2015 by approximately 15%. The company has updated its full year 2015 GAAP diluted earnings per share from continuing operations range from $4.13 to $4.28 to a range of $4.23 to $4.38, reflecting an expected reduction in 2015 forecasted restructuring, impairment charges and special items, net of tax. Diluted earnings per share attributable to common shareholders is expected to be between $4.23-$4.38.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TBH:GR €111.13 EUR 0.00

TBH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IDEXX Laboratories Inc $72.91 USD +2.37
PerkinElmer Inc $47.56 USD +1.14
ResMed Inc $51.91 USD +1.16
Sirona Dental Systems Inc $94.06 USD +1.01
STERIS Corp $63.78 USD +1.47
View Industry Companies
 

Industry Analysis

TBH

Industry Average

Valuation TBH Industry Range
Price/Earnings 31.4x
Price/Sales 2.9x
Price/Book 2.7x
Price/Cash Flow 27.9x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit www.teleflex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.